Patents by Inventor Stephen Shanahan

Stephen Shanahan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9049864
    Abstract: The present invention relates to compounds of Formula (I), or an agronomically acceptable salt of said compounds wherein X1, R1, R2, R3, R5, G and n are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I), and to their use for controlling weeds, in particular in crops of useful plants.
    Type: Grant
    Filed: April 12, 2013
    Date of Patent: June 9, 2015
    Assignee: Syngenta Limited
    Inventors: Paul Burton, Anthony Kozakiewicz, James Morris, Christopher John Mathews, Stephen Shanahan
  • Publication number: 20150031540
    Abstract: The present invention relates to compounds of Formula (I), or an agronomically acceptable salt of said compounds wherein X1, R1, R2, R3, R5, G and n are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I), and to their use for controlling weeds, in particular in crops of useful plants.
    Type: Application
    Filed: April 12, 2013
    Publication date: January 29, 2015
    Applicant: SYNGENTA LIMITED
    Inventors: Paul Burton, Anthony Kozakiewicz, James Morris, Christopher John Mathews, Stephen Shanahan
  • Publication number: 20070293564
    Abstract: A method for the prevention of an orthomyxovirus or paramyxovirus infection comprising the step of administration to a subject in need thereof of an effective amount of a compound of formula (I)
    Type: Application
    Filed: December 4, 2006
    Publication date: December 20, 2007
    Inventors: Michael Dowle, Betty Jin, Simon MacDonald, Andrew Mason, Darryl McConnell, Van Nguyen, Stephen Shanahan, Wen-Yang Wu
  • Publication number: 20070225359
    Abstract: The invention relates to compounds of general formula (I); in which R is an amino or guanidino group; R2 is acetyl or trifluoroacetyl; and n is an integer from 10 to 18 or a pharmaceutically acceptable derivative thereof, methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection.
    Type: Application
    Filed: May 21, 2007
    Publication date: September 27, 2007
    Inventors: Derek DEMAINE, Graham Inglis, Simon MacDonald, Stephen Shanahan, Simon Tucker, Keith Watson, Wen-Yang Wu
  • Publication number: 20070225358
    Abstract: The invention relates to compounds of general formula (I); in which R is an amino or guanidino group; R2 is acetyl or trifluoroacetyl; X is CONH, NHCO or O; n is an integer from 2 to 6; and Y is C2-C9 alkyl C3-8 cycloalkyl, C1-C4 alkoxyalkyl, an amino acid or dipeptide, or a pharmaceutically acceptable derivative thereof, methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection.
    Type: Application
    Filed: April 12, 2007
    Publication date: September 27, 2007
    Inventors: Betty JIN, Simon MacDonald, Darryl McConnell, Van Nguyen, Stephen Shanahan, Wen-Yang Wu
  • Publication number: 20070225361
    Abstract: The invention relates to compounds of general formula (I), in which: R is an amino or guanidino group; R2 is acetyl or trifluoroacetyl; n and q are either the same or different and selected from 0, 1 or 2; and X is an optionally substituted phenyl, optionally substituted naphthyl or optionally substituted phenyl-Y-optionally substituted phenyl in which Y is selected from a covalent bond, CH2, CH2CH2, O or SO2, or a pharmaceutically acceptable derivative thereof, with the proviso that when X is phenyl or naphthyl, n and q are both 2 and when X is phenyl-Y-phenyl in which Y is a covalent bond, then n and q are not both 0, methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection.
    Type: Application
    Filed: April 2, 2007
    Publication date: September 27, 2007
    Inventors: Derek Demaine, Haydn Jones, Simon MacDonald, Andrew Mason, Stephen Shanahan
  • Publication number: 20050054719
    Abstract: The invention relates to compounds of general formula (1); in which R is an amino or guanidino group; R2 is acetyl or trifluoroacetyl; X is CONH, NHCO or O; n is an integer from 2 to 6; and Y is C2-C8 alkyl C3-8 cycloalkyl, C1-C4 alkoxyalkyl, an amino acid or dipeptide, or a pharmaceutically acceptable derivative thereof, methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection.
    Type: Application
    Filed: November 8, 2002
    Publication date: March 10, 2005
    Inventors: Betty Jin, Simon MacDonald, Darryl McConnell, Van Nguyen, Stephen Shanahan, Wen-Yang Wu
  • Publication number: 20050054718
    Abstract: The invention relates to compounds of general formula (I), in which: R is an amino or guanidino group; R2 is acetyl or trifluoroacetyl; n and q are either the same or different and selected from 0, 1 or 2; and X is an optionally substituted phenyl, optionally substituted naphthyl or optionally substituted phenyl-Y-optionally substituted phenyl in which Y is selected from a covalent bond, CH2, CH2CH2, O or SO2, or a pharmaceutically acceptable derivative thereof, with the proviso that when X is phenyl or naphthyl, n and q are both 2 and when X is phenyl-Y-phenyl in which Y is a covalent bond, then n and q are not both 0, methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection.
    Type: Application
    Filed: November 8, 2002
    Publication date: March 10, 2005
    Inventors: Derek Demaine, Haydn Jones, Simon MacDonald, Andrew McMason, Stephen Shanahan
  • Publication number: 20050043399
    Abstract: The invention relates to compounds of general formula (I); in which R is an amino or guanidino group; R2 is acetyl or trifluoroacetyl; and n is an integer from 10 to 18 or a pharmaceutically acceptable derivative thereof, methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection.
    Type: Application
    Filed: November 8, 2002
    Publication date: February 24, 2005
    Inventors: Derek Demaine, Graham Inglis, Simon MacDonald, Stephen Shanahan, Simon Tucker, Keith Watson, Wen-Yang Wu